ipilimumab and nivolumab for newly diagnosed glioblastoma (gbm)
Published 2 years ago • 41 plays • Length 3:32Download video MP4
Download video MP3
Similar videos
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
2:11
ipilimumab and nivolumab for melanoma brain metastases
-
4:00
ipilimumab plus nivolumab for mcrpc
-
5:23
nivolumab vs bevacizumab in patients with recurrent glioblastoma
-
5:58
nivolumab plus bevacizumab for recurrent glioblastoma
-
2:25
cabozantinib with nivolumab and ipilimumab for genitourinary malignancies
-
9:06
implications of new nivolumab and ipililumab combination data in melanoma brain metastases
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
4:20
gestalt trial for newly diagnosed gbm
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
58:45
webinar: michael lim, md - immunotherapy for brain tumors
-
6:03
improved survival with ttfields and temozolomide in newly diagnosed glioblastoma
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
3:58
no survival benefit from bevacizumab in elderly gbm patients
-
1:09
dr. patel on benefit of ipilimumab/nivolumab combo in high-grade neuroendocrine carcinoma
-
8:17
new data on the management of recurrent gbm: practical implications
-
3:16
optimizing the use of ipilimumab/nivolumab in mrcc